Yale Catriona's Form 4 filing
Akero Therapeutics, Inc. (AKRO) · filed Mar 6, 2024
- Accession no.
- 0000950170-24-027509
- Filed
- Mar 6, 2024
- Trade date
- Mar 4, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $732.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yale CatrionaCIK 0001779308 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $6.36 | +$63,600 | 88,415 | Direct | |
| Mar 4, 2024 | Common Stock | MOption exerciseAcquired | +10,646 | $21.09 | +$224,524.14 | 99,061 | Direct | |
| Mar 4, 2024 | Common Stock | SSaleDisposed | −20,646 | $35.49 | −$732,726.54 | 78,415 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 15,172 | Direct | |
| Mar 4, 2024 | Common Stock | MOption exerciseDisposed | −10,646 | $0.00 | $0 | 74,354 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.